Stay updated on Zephyrus I Clinical Trial
Sign up to get notified when there's something new on the Zephyrus I Clinical Trial page.

Latest updates to the Zephyrus I Clinical Trial page
- CheckyesterdayChange DetectedKyntra Bio has been added as sponsor and FibroGen removed, and the page revision has been updated to v3.3.4.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe Locations section has been expanded with many new study sites across the United States, Argentina, Australia, and China, and the revision tag updated to v3.3.3.SummaryDifference3%

- Check51 days agoChange DetectedObserved a minor page metadata update: Revision: v3.3.2 added and Revision: v3.3.1 removed; no changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange Detected- Added automatic PubMed publications note and updated the page revision to v3.3.1.SummaryDifference0.0%

- Check65 days agoChange DetectedRemoved the government funding lapse notice from the page, which previously described potential delays and operating status; the page now presents the trial details without that disclaimer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedMinor layout changes to the study locations section with no alterations to core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Zephyrus I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zephyrus I Clinical Trial page.